These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 760933)

  • 1. Role of catecholamines in hypotensive response to dieting.
    Jung RT; Shetty PS; Barrand M; Callingham BA; James WP
    Br Med J; 1979 Jan; 1(6155):12-3. PubMed ID: 760933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of refeeding after semistarvation on catecholamine and thyroid metabolism.
    Jung RT; Shetty PS; James WP
    Int J Obes; 1980; 4(2):95-100. PubMed ID: 7399806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of modified fasting on blood pressure and sympathetic activity: a correlation?
    Koppeschaar HP; Meinders AE; Schwarz F
    Int J Obes; 1983; 7(6):569-74. PubMed ID: 6654573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity and precursor availability affect urinary catecholamine metabolite production in women.
    Johnston JL; Warsh JJ; Anderson GH
    Am J Clin Nutr; 1983 Sep; 38(3):356-68. PubMed ID: 6613910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight-reducing diets: role of carbohydrates on sympathetic nervous activity and hypotensive response.
    Fagerberg B; Andersson O; Nilsson U; Hedner T; Isaksson B; Björntorp P
    Int J Obes; 1984; 8(3):237-43. PubMed ID: 6746191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity-related hypertension: evaluation of the separate effects of energy restriction and weight reduction on hemodynamic and neuroendocrine status.
    Weinsier RL; James LD; Darnell BE; Dustan HP; Birch R; Hunter GR
    Am J Med; 1991 Apr; 90(4):460-8. PubMed ID: 2012086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure control during weight reduction in obese hypertensive men: separate effects of sodium and energy restriction.
    Fagerberg B; Andersson OK; Isaksson B; Björntorp P
    Br Med J (Clin Res Ed); 1984 Jan; 288(6410):11-4. PubMed ID: 6418295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autonomic responsiveness in obesity with and without hypertension.
    James WP; Haraldsdottir J; Liddell F; Jung RT; Shetty PS
    Int J Obes; 1981; 5 suppl 1():73-8. PubMed ID: 7239775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dexfenfluramine treatment on body weight, blood pressure and noradrenergic activity in obese hypertensive patients.
    Kolanowski J; Younis LT; Vanbutsele R; Detry JM
    Eur J Clin Pharmacol; 1992; 42(6):599-605. PubMed ID: 1623900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma catecholamines and autonomic responsiveness in obesity.
    Jung RT; Shetty PS; James WP; Barrand MA; Callingham BA
    Int J Obes; 1982; 6(2):131-41. PubMed ID: 7095970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in resting metabolic rate and ratio of plasma leptin to urinary nitric oxide: influence on obesity-related hypertension.
    Golan E; Tal B; Dror Y; Korzets Z; Vered Y; Weiss E; Bernheim J
    Isr Med Assoc J; 2002 Jun; 4(6):426-30. PubMed ID: 12073415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of sodium supplementation during energy restriction on plasma norepinephrine levels in obese women.
    Gougeon R; Mitchell TH; Larivière F; Abraham G; Montambault M; Marliss EB
    J Clin Endocrinol Metab; 1991 Nov; 73(5):975-81. PubMed ID: 1939535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitrogen and sodium balance and sympathetic-nervous-system activity in obese subjects treated with a low-calorie protein or mixed diet.
    DeHaven J; Sherwin R; Hendler R; Felig P
    N Engl J Med; 1980 Feb; 302(9):477-82. PubMed ID: 7351972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resting metabolic rate, fat-free mass and catecholamine excretion during weight loss in female obese patients.
    Menozzi R; Bondi M; Baldini A; Venneri MG; Velardo A; Del Rio G
    Br J Nutr; 2000 Oct; 84(4):515-20. PubMed ID: 11103222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications.
    Bravo EL; Tarazi RC; Gifford RW; Stewart BH
    N Engl J Med; 1979 Sep; 301(13):682-6. PubMed ID: 481462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pheochromocytoma and hypophysectomy on blood pressure and catecholamines in NEDH rats.
    Manger WM; Hulse MC; Forsyth MS; Chute RN; Brown CE; Webb K; Sussman R; Warren S
    Hypertension; 1982; 4(3 Pt 2):200-7. PubMed ID: 7068205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of catecholamine replacement with levodopa on the metabolic response to semistarvation.
    Shetty PS; Jung RT; James WP
    Lancet; 1979 Jan; 1(8107):77-9. PubMed ID: 84131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catecholamine metabolism during heroin use.
    Schildkraut JJ; Meyer RE; Orsulak PJ; Mirin SM; Roffman M; Platz PA; Grab E; Randall ME; McDougle M
    Am J Psychiatry; 1977 May; 134(5):534-7. PubMed ID: 848581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the sympathetic nervous system in blood pressure maintenance in obesity.
    Sowers JR; Whitfield LA; Catania RA; Stern N; Tuck ML; Dornfeld L; Maxwell M
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1181-6. PubMed ID: 7042733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phentolamine tests and catecholamine levels in normotensive CVA patients.
    Favazza AR
    Dis Nerv Syst; 1974 Nov; 35(11):515-9. PubMed ID: 17896460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.